Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 704 results found. Search for [ COVID-19 scientists ]

Results 1 to 21 of 704
Reuters
June 24, 2021
The estimate is included in a report, which is to be discussed on Thursday at a board meeting of Gavi, a vaccine alliance that co-leads the WHO's Covid-19 vaccine programme COVAX


BusinessToday.In
June 24, 2021
Cases of heart inflammation are higher in the week following the second dose of the COVID-19 vaccine and in males, as per the data available with the CDC


PTI
June 23, 2021
The findings by researchers at the Stanford School of Medicine, US, and Saarland University in Germany may help explain why many COVID-19 patients report neurological problems


Reuters
June 23, 2021
The study by Oxford university investigated the ability of monoclonal antibodies in Sera from recovered people and from vaccinated people to neutralize the Delta and Kappa variants


PTI
June 20, 2021
The state is planning to reverse the gender ratio in the 26,000 COVID beds at state-run and private hospitals, Director of Health Services Ajay Chakraborty said


PTI
June 19, 2021
Professor Andrew Pollard noted that in India, the vast majority of the population is unvaccinated and, therefore, unprotected at a time when the Delta variant is a widespread and increasing threat


BusinessToday.In
June 18, 2021
The results of the UK study suggest that there is a loss of grey matter in the areas of the brain associated with smell/taste and cognitive function and memory


BusinessToday.In
June 16, 2021
The Union Health Ministry increased the gap between two doses of the jab in May from 6-8 weeks to 12-16 weeks, citing a shortfall. The ministry further added this extension was recommended by the NTAGI


BusinessToday.In
New Delhi, June 15, 2021
In May, the WHO tagged B.1.617.2 strain as the 'Delta' variant of SARS-CoV-2. The variant was identified as one of the drivers of the second wave of coronavirus infections that devastated parts of the country earlier this year. The 'Delta' variant has further mutated to form the 'Delta plus' or 'AY.1' variant. Initial data suggests that the Delta plus variant shows signs of resistance against the monoclonal antibody cocktail treatment that was recently authorised by the Central Drugs Standard Control Organisation (CDSCO). However, scientists say there is no immediate cause for concern since the prevalence of this new variant is still low in India.Also Read: COVID-19: New 'Delta plus' variant of SARS-CoV-2 emerges; all you need to know


BusinessToday.In
June 15, 2021
Initial tests show antiviral activity effective against SARS CoV-2, the virus that causes COVID-19, by inhibiting 90% of the virus' replication in vitro studies


BusinessToday.In
June 15, 2021
According to initial reports, this new Delta plus variant has shown signs of resistance against the monoclonal antibody cocktail treatment which was recently approved by the Central Drugs Standard Control Organisation (CDSCO)


PTI
June 15, 2021
Scientists advising the government had warned there could be a \"significant resurgence\" in people needing hospital treatment for COVID-19 if stage four of easing the lockdown went ahead on June 21


Reuters
June 14, 2021
Honeywell said its researchers will collaborate with Indian scientists to test and validate suitability of adsorbents for oxygen production in India


PTI
June 13, 2021
UK Foreign Secretary Dominic Raab said that officials \"compared notes\" over the theory that the pandemic may have originated from a leak from a lab in Wuhan


BusinessToday.In
June 12, 2021
An international team of researchers conducted the study to ascertain why severe symptoms and adverse outcomes are experienced by some people who are infected with COVID-19 and not others


PTI
June 12, 2021
Prior infections, high seropositivity and partial vaccination are \"insufficient impediments\" to the spread of the Delta variant, found the scientists


BusinessToday.In
June 11, 2021
Through its virtual reality (VR) app, US-based startup Nanome licenses its technology to scientists in their research of diseases as well as pharma companies aiming to design new drugs


PTI
June 11, 2021
In their latest report, medical experts from IPHA, IAPSM, and IAE said vaccinating the vulnerable and those at risk should be the aim at present


Manu Kaushik
New Delhi, June 9, 2021
The pandemic has opened a fresh debate around the future of 5G in India. Infrastructure requirements could further delay its launch


BusinessToday.In
June 9, 2021
'Joint for jab' offer is one among many other incentives being given by various states in the US as the country registers record number of vaccinations. Other incentives announced by the state of Washington include lottery prizes, sports tickets and game systems


PAGES 1 OF 36  12345